
Prof. Oliver Lieleg and PhD student Ceren Kimna use balls and pipe cleaners in different colors to visualize how nanoparticles can be bound together by DNA fragments. Such connections may become the basis of drugs that release their active ingredients in sequence.
Image: Uli Benz / TUM
A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was once a pharmacologist’s dream is now much closer to reality. With a combination of hydrogels and artificial DNA, nanoparticles can be released in sequence under conditions similar to those in the human body.
It is becoming much more common for patients to be treated with several different medications. It is often necessary for the patient to take them at fixed intervals – a limitation that makes everyday life difficult and increases the risk of doses being skipped or forgotten.
Oliver Lieleg, Professor of Biomechanics and a member of the Munich School of BioEngineering at TUM, and doctoral candidate Ceren Kimna have now developed a process that could serve as the basis for medications containing several active ingredients that would reliably release them in the body in a pre-defined sequence at specified times. “For example, an ointment applied to a surgical incision could release pain medication first, followed by an anti-inflammatory drug and then a drug to reduce swelling,” explains Oliver Lieleg.
One active ingredient after the other
“Ointments or creams releasing their active ingredients with a time delay are not new in themselves,” says Oliver Lieleg. With the drugs currently in use, however, there is no guarantee that two or more active ingredients will not be released into the organism simultaneously.
To test the principle behind their idea, Oliver Lieleg and Ceren Kimna used nanometer-sized silver, iron oxide and gold particles embedded in a special gel-like substance known as a hydrogel. They then used a spectroscopic method to track the exit of the particles from the gel. The particles selected by the researchers have similar motion characteristics within the gel to the particles used to transport real active ingredients, but are easier and cheaper to make.
The special ingredient controlling the nanoparticles is artificial DNA. In nature, DNA is above all the carrier of genetic information. However, researchers are increasingly exploiting another property: The ability of DNA fragments to be combined with great accuracy, both in terms of the types of bonds and their strength, for example to build machines on a nanometer scale.
The DNA cascade: compress and then release at the right instant
The silver particles were released first. In the initial state, the particles were bound together by DNA fragments designed by Lieleg and Kimna using special software. The resulting particle clusters are so large that they are unable to move in the hydrogel. However, when a saline solution is added, they separate from the DNA. They can now move in the gel and drift to the surface. “Because the saline solution has approximately the same salinity as the human body, we were able to simulate conditions where the active ingredients would not be released until the medication is applied,” explains Ceren Kimna.
The mesh-like DNA structure surrounding the iron oxide particles consists of two types of DNA: The first has one end attached to the iron oxide particles. The second type is attached to the loose ends of the first type. These structures are not affected by the saline solution. The iron oxide particles can only be released when the first clusters have dissolved. This event releases not only the silver nanoparticles, but also DNA, which eliminates the “connection DNA” of the second cluster without forming connections itself. As a result, the iron oxide particles can separate. This releases DNA fragments which in turn act as the key to the third DNA-nanoparticle combination.
“The consistency of ointments makes them the most obvious solution for a hydrogel-based approach. However, this principle also has the potential to be used in tablets that could release several effective ingredients in the body in a specific order,” explains Prof. Lieleg.
Learn more: One at a time
The Latest on: Drug delivery
via Google News
The Latest on: Drug delivery
- Novartis invests in Credence for injectable delivery scale-upon January 26, 2021 at 4:30 am
Novartis has invested in Credence MedSystems to support the development and scale-up of its drug delivery systems. Credence will use the money to advance an injectable system designed to improve the ...
- Liposomes Drug Delivery Market Size, Trends, Companies, Driver, Segmentation, Forecast by 2026on January 26, 2021 at 4:23 am
Selbyville, Delaware, report on Global Liposomes Drug Delivery Market explores the essential factors of Liposomes Drug Delivery industry covering current scenario, market demand information, coverage ...
- Global Novel Drug Delivery Systems Market 2020 In-depth Assessment, Key Trend, Industry Drivers, Future Roadmap by 2025on January 26, 2021 at 12:16 am
MarketsandResearch.biz has published the latest and most trending report entitled Global Novel Drug Delivery Systems Market 2020 by Company, Type and Application, Forecast to 2025 that collates ...
- BioMed X Institute Starts New Research Project in Drug Delivery in Collaboration with Janssenon January 26, 2021 at 12:03 am
BioMed X Institute Starts New Research Project in Drug Delivery in Collaboration with JanssenBioMed X Institute expands its collaboration, facilitated by Johnson & Johnson Innovation, with a third ...
- New drug delivery plea achieves probationon January 25, 2021 at 11:22 am
John Giovino was granted an opportunity Monday to present a new plea that allowed him to serve his sentence, for intent to deliver marijuana, from his own home in Philadelphia ...
- Microneedle Drug Delivery Systems Market will grow at a CAGR of 6.6% between 2020 and 2030on January 21, 2021 at 5:44 am
Players in the microneedle drug delivery system market are leveraging growing demand for minimally invasive, pain-free therapeutic options for infectious ...
- Drug-delivery microcapsules tagged with zirconium-89 can be tracked by PET imagingon January 20, 2021 at 4:00 pm
Polymer and radionuclide chemists report major advance in microcapsule drug delivery systems. Their microcapsules -- labeled with radioactive zirconium-89 -- are the first example of hollow polymer ...
- Controlled Release Drug Delivery Market Augmented Expansion to be registered until 2030 | Depomed Inc, Coating Place Incon January 19, 2021 at 9:22 pm
MarketResearch.Biz –:An extensive and elaborate primary research on Global Controlled Release | eTurboNews | Trends | Travel News Online | ...
- Drug delivery death trial begins in Beaver Countyon January 19, 2021 at 2:05 pm
An Aliquippa woman is charged following the fatal overdose of Stephen Naim – the brother of former Aliquippa Police Officer Jimmy Naim, who was killed on the job two decades ago.
- Nasal Drug Delivery Systems Market Industry Summary, Competitive Status, Restraints and Threat, Forecast Till 2030 | Merck & Co. Inc and Novartis AGon January 15, 2021 at 11:01 am
MarketResearch.Biz :Nasal Drug Delivery Systems Market Overview: The report provides quantitative and qualitative information on the global Nasal Drug Delivery Systems market for the period of 2021 to ...
via Bing News